Healthcare >> CEO Interviews >> January 10, 2005

ROBERT FOSTER – ISOTECHNIKA INC (ISA:TSX)

ROBERT FOSTER, Chairman, Chief Executive Officer and a Director of Isotechnika Inc., has been a director and officer of Isotechnika since he founded the company in 1993. He brings to the company expertise acquired through his education, his teaching responsibilities, and the publication of over 125 scientific papers, articles and book chapters focused on drug development and analysis. He has received numerous grants and awards for both pharmaceutical research and teaching. Additionally, Dr. Foster holds several pharmaceutical patents. Dr. Foster was a tenured Associate Professor (clinical pharmacokinetics) in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta for a period of approximately nine years. During this time, he also served for two years as Chairman of Pharmacy Practice and numerous other university committees. He currently remains as Adjunct Full Professor in the faculty. Dr. Foster was also Medical Staff, Scientific and Research Associate in the Department of Laboratory Medicine at the Walter C. Mackenzie Health Sciences Centre from 1990 to 1994. Dr. Foster has served on the Alberta Science and Research Authority Technology Commercialization Task Force, and was a member of the Board of Management for the Alberta Research and Science Authority. Dr. Foster also served on the Premier's Advisory Council on Health. In addition, he has served on other companies' Boards, is a member of numerous scientific associations, a board member of BioAlberta, on the Board of Management of the Alberta Economic Development Authority, and has served as a consultant with many pharmaceutical companies. Since founding the company in 1993, Dr. Foster has assembled the core scientific and business team that has led the company to its current successes. Dr. Foster, along with the other senior executive team members, has raised close to $200 million through various equity financings in North America and abroad. As Chairman and CEO of Isotechnika Inc., Dr. Foster and his team have taken Isotechnika Inc. to become one of Canada's leading biotechnology companies, listed on the TSX. Profile
TWST: Would you give us a brief historical sketch of the company and a

picture of the things you are doing now?

Dr. Foster: Isotechnika was incorporated in June 1993 and was